Biovail, GSK Want Wellbutrin Antitrust Suit Tossed
The motions, filed Thursday in the U.S. District Court for the Eastern District of Pennsylvania, seek to dismiss the complaint in its entirety.
Biovail argued in its motion that the claims of monopolization under state law, unfair and deceptive practices under state law and unjust enrichment could not...
Already a subscriber? Click here to login